Back to Search Start Over

Measurement of dose enhancement factor for Xoft Axxent electronic brachytherapy device using nanoparticle-embedded alginate film and radiochromic film.

Authors :
Kakade, Nitin R.
Das, Abhishek
Kumar, Rajesh
Sharma, S. D.
Maiti, Nandita
Chadha, Ridhima
Sapra, B. K.
Source :
Journal of Cancer Research & Therapeutics; 2023 Supplement, Vol. 19, pS177-S182, 6p
Publication Year :
2023

Abstract

Aim: In nanoparticles-aided radiotherapy, the radiation sensitivity of tumor is increased with the infusion of nanoparticles in tumor. This therapeutic modality is capable of delivering enhanced dose to tumor, without exceeding the normal tissue tolerance dose. Further, the quantification of the enhanced dose using suitable dosimeter is important. The present study is aimed at measuring the dose enhancement factors (DEFs) using the combination of nanoparticles-embedded alginate (Alg) film and unlaminated Gafchromic EBT3 film. Materials and Methods: Gold nanoparticles (AuNPs)- and silver nanoparticles (AgNPs)-embedded Alg polymer films were synthesized and characterized using standard techniques. Further, a customized version of the Gafchromic EBT3 film, i.e., unlaminated EBT3 film, was specially fabricated. The DEFs were measured using Xoft Axxent electronic brachytherapy device. Results: The surface plasmon resonance (SPR) and particle size of AuNPs were found to be 550 and 15 ± 2 nm, respectively. In the case of AgNPs, the SPR and particle size were recorded as 400 and 13 ± 2 nm, respectively. The DEFs measured, using unlaminated EBT3 film, for Xoft Axxent electronic brachytherapy using AuNPs and AgNPs were 1.35 ± 0.02 and 1.20 ± 0.01, respectively. Conclusion: The increase in dose enhancement during nanoparticles-aided electronic brachytherapy can be attributed to dominance of photoelectric effect, due to the presence of low-energy X-rays. The investigation indicates that the Xoft Axxent electronic brachytherapy device is suitable for nanoparticles-aided brachytherapy. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09731482
Volume :
19
Database :
Complementary Index
Journal :
Journal of Cancer Research & Therapeutics
Publication Type :
Academic Journal
Accession number :
171889400
Full Text :
https://doi.org/10.4103/jcrt.jcrt_207_21